Genetic studies have revealed that most HHT patients carry mutations in the genes ENG (encoding endoglin)7 or ACVRL1 (activin receptor-like kinase 1, ALK1)8, which define the two disease subtypes HHT1 and HHT2, respectively9. The gene discussed is ENG; the disease is hereditary hemorrhagic telangiectasia.